Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24 20:21 | 4/30/24 | CDMO | Health | Drug | Pharmaceutical Preparations | Ziebell Mark R | CA | O | V. P.,GC | 1 | S | -12 | 7.40 | 0 | -2 | 65 | D | |||||||||||||||
5/2/24 20:21 | 4/30/24 | CDMO | Health | Drug | Pharmaceutical Preparations | Richieri Richard A. | CA | O | Chief Op | 1 | S | -8 | 7.40 | 0 | -1 | 32 | M | |||||||||||||||
5/2/24 20:20 | 4/30/24 | CDMO | Health | Drug | Pharmaceutical Preparations | Kwietniak Matthew R. | CA | O | Chief Co | 1 | S | -9 | 7.40 | 0 | -1 | 22 | D | |||||||||||||||
5/2/24 20:20 | 4/30/24 | CDMO | Health | Drug | Pharmaceutical Preparations | Hart Daniel R | CA | O | CFO | 1 | S | -21 | 7.40 | 0 | -3 | 82 | D | |||||||||||||||
5/2/24 20:20 | 4/30/24 | CDMO | Health | Drug | Pharmaceutical Preparations | Green Nicholas Stewart | CA | DO | P,CEO | 1 | S | -87 | 7.40 | 0 | -12 | 204 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |